Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis (Q36488777)

14 August 2017

Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis (English)

1 reference

14 August 2017

0 references

0 references

0 references

0 references

Edith T Zemanick

5

0 references

Brandie D Wagner

object named as

Brandie D Wagner

2

0 references

author name string

Scott D Sagel

1

1 reference

14 August 2017

Margaret M Anthony

3

1 reference

14 August 2017

Peggy Emmett

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

16 August 2012

1 reference

American Journal of Respiratory and Critical Care Medicine

14 August 2017

1 reference

14 August 2017

186

1 reference

14 August 2017

9

1 reference

14 August 2017

857-865

1 reference

17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Potential role of high-mobility group box 1 in cystic fibrosis airway disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Sputum biomarkers of inflammation in cystic fibrosis lung disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Association between pulmonary function and sputum biomarkers in cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Mixed models for longitudinal left-censored repeated measures

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Analysis of left-censored longitudinal data with application to viral load in HIV infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Standardization of Spirometry, 1994 Update. American Thoracic Society

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Random-effects models for longitudinal data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Microbiology of sputum from patients at cystic fibrosis centers in the United States

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Pulmonary function between 6 and 18 years of age.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.201203-0507OC

alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients

21 January 2018

1 reference

12 December 2020

Elastin and collagen degradation products in urine of patients with cystic fibrosis

1 reference

12 December 2020

Aerosol α1 -antitrypsin treatment for cystic fibrosis

1 reference

12 December 2020

Prolastin aerosol therapy and sputum taurine in cystic fibrosis

1 reference

12 December 2020

Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis

1 reference

12 December 2020

Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis

1 reference

12 December 2020

Genetic modifiers of lung disease in cystic fibrosis

1 reference

12 December 2020

Sputum induction in routine clinical care of children with cystic fibrosis

1 reference

12 December 2020

Sputum and serum calprotectin are useful biomarkers during CF exacerbation

1 reference

12 December 2020

Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis

1 reference

12 December 2020

Predictors of deterioration of lung function in cystic fibrosis

1 reference

12 December 2020

alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis

1 reference

12 December 2020

Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis

1 reference

12 December 2020

Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis

1 reference

12 December 2020

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

1 reference

12 December 2020

10.1164/RCCM.201203-0507OC

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

1 reference